Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Activity
RulesProposed and final rules open for commentGrantsFederal funding opportunities and deadlinesPress releasesWhat agencies are announcing publiclyHearingsCongressional committee hearings and meetingsBillsLegislation, actions, amendments, and votes
Views
AgenciesEverything from a single federal agencyTopicsActivity grouped by policy areaOrganizationsCompanies, associations, and advocacy groupsCommitteesHouse, Senate, and joint committee activityLegislatorsMembers of Congress, service, bills, and votes
Pricing
LoginCreate account

Table of contents

DetailsRelated

Background Material

FDA-1988-N-0028-0004Supporting & Related Material
Document

Details

The document's own metadata, straight from the source system.

Title
Background Material
Posted
Nov 10, 2004
Agency
Food and Drug Administration (FDA)
Topics
  • Pharmaceutical Policy
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Notice
Pediatric Dosing with Over-the-Counter Drug Products; Summary Information Document for Advisory Committee Meeting; Availability; Establishment of a Public Docket and Request for Comments
ClosedDec 27, 1994
Notice
Pediatric Dosing Information for Over-the-Counter Human Drugs; Intent and Request for Information
Closed · 1Jun 29, 1988
Other
Memorandum from FDA CDER to FDA DMB
No comment periodJun 20, 1988

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ActivityRulesGrantsPress releases
ViewsAgenciesTopicsOrganizations
GuidesInstall Government ContextFive questions to ask your agentAll guides
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.